4.2K views · 116 reactions | First-line chemotherapy results in poor overall survival in advanced esophageal cancer. Incorporating immune checkpoint inhibitors into first-line treatment might improve outcomes. New research findings are summarized in a short video. https://nej.md/342rUGR | The New England Journal of Medicine | Facebook

1.1K views · 42 reactions | Advances in esophageal cancer treatments can mean even better outcomes for patients. Thoracic surgery expert Robert Merritt, MD, discusses a procedure that is available only at certain centers in the United States — the OSUCCC – James is the only facility in the region to offer this advanced treatment option. | OSUCCC-James Cancer Hospital and Solove Research Institute | Facebook